Anavex Life Sciences Corp. Gains 35.85%
Anavex Life Sciences Corp. (AVXL:NASDAQ) rocketted at $12.05, a gain of 35.9%. On Fri, Dec 02, 2022, AVXL:NASDAQ touched a New 2-Week High of $12.05. The stock got featured on our News Catalysts scanner on Fri, Dec 02, 2022 at 03:00 AM in the 'BIOTECH' category. From Fri, Nov 18, 2022, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Mon, Nov 14, 2022 at $15.24 with a volume of 1M+.
About Anavex Life Sciences Corp. (AVXL:NASDAQ)
Anavex Life Sciences Corp is a clinical stage bio-pharmaceutical company. The Company is engaged in the developments drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, and various types of cancer.
Top 10 Gainers:
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 65.07%
- Sunlands Technology Group (STG:NYSE), 50.11%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 46.69%
- Ra Medical Systems, Inc. (RMED:NYSE), 46.06%
- Gelesis Holdings Inc. (GLS:NYSE), 39.29%
- FLJ Group Limited (FLJ:NASDAQ), 36.42%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 35.85%
- Getnet Adquirencia e Servicos para Meios de Pagamento S.A. (GET:NASDAQ), 34.1%
- Zhihu Inc. American Depositary Shares (every two of each representing one Class A) (ZH:NYSE), 33.33%
- Pintec Technology Holdings Limited (PT:NASDAQ), 33.33%